Author:
Choi Y J,Lim H T,Lee S J,Lee S Y,Yoon J S
Publisher
Springer Science and Business Media LLC
Reference14 articles.
1. Burch HB, Wartofsky L . Graves’ ophthalmopathy: current concepts regarding pathogenesis and management. Endocr Rev 1993; 14 (6): 747–793.
2. Weetman AP . Thyroid-associated eye disease: pathophysiology. Lancet 1991; 338 (8758): 25–28.
3. Bartalena L, Pinchera A, Marcocci C . Management of Graves’ ophthalmopathy: reality and perspectives. Endocr Rev 2000; 21 (2): 168–199.
4. Gerding MN, Terwee CB, Dekker FW, Koornneef L, Prummel MF, Wiersinga WM . Quality of life in patients with Graves’ ophthalmopathy is markedly decreased: measurement by the medical outcomes study instrument. Thyroid 1997; 7 (6): 885–889.
5. Bradley EA, Sloan JA, Novotny PJ, Garrity JA, Woog JJ, West SK . Evaluation of the National Eye Institute visual function questionnaire in Graves’ ophthalmopathy. Ophthalmology 2006; 113 (8): 1450–1454.
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献